Follow
Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID  D-6906-2014)
Jacek Kubica, MD PhD, FESC (orcid.org/0000-0001-8250-754X; Web of Science ResearcherID D-6906-2014)
Nicolaus Copernicus University, Collegium Medicum, Dept. of Cardiology and Internal Medicine
Verified email at cm.umk.pl
Title
Cited by
Cited by
Year
Effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis
EP Navarese, M Kołodziejczak, V Schulze, PA Gurbel, U Tantry, Y Lin, ...
Annals of internal medicine 163 (1), 40-51, 2015
5482015
Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis
EP Navarese, JG Robinson, M Kowalewski, M Kołodziejczak, F Andreotti, ...
Jama 319 (15), 1566-1579, 2018
4812018
Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus
EP Navarese, A Buffon, F Andreotti, M Kozinski, N Welton, T Fabiszak, ...
The American journal of cardiology 111 (8), 1123-1130, 2013
3892013
Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial
J Kubica, P Adamski, M Ostrowska, J Sikora, JM Kubica, WD Sroka, ...
European heart journal 37 (3), 245-252, 2016
3222016
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice …
EP Navarese, K Tandjung, B Claessen, F Andreotti, M Kowalewski, ...
Bmj 347, 2013
2572013
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
2542019
Optimal timing of coronary invasive strategy in non–ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis
EP Navarese, PA Gurbel, F Andreotti, U Tantry, YH Jeong, M Kozinski, ...
Annals of internal medicine 158 (4), 261-270, 2013
2002013
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study
G Montalescot, B Pitt, E Lopez de Sa, CW Hamm, M Flather, F Verheugt, ...
European heart journal 35 (34), 2295-2302, 2014
1972014
Cause of death and predictors of all‐cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF
SD Pokorney, JP Piccini, SR Stevens, MR Patel, KS Pieper, JL Halperin, ...
Journal of the American Heart Association 5 (3), e002197, 2016
1562016
Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention
EP Navarese, M Kowalewski, F Andreotti, M van Wely, C Camaro, ...
The American journal of cardiology 113 (10), 1753-1764, 2014
1382014
First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials …
EP Navarese, M Kowalewski, D Kandzari, A Lansky, B Górny, Ł Kołtowski, ...
Open heart 1 (1), e000064, 2014
1272014
Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials
EP Navarese, SU Khan, M Kołodziejczak, J Kubica, S Buccheri, ...
Circulation 142 (2), 150-160, 2020
1262020
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS‐PCI study
JM SILLER‐MATULA, G Delle‐Karth, IM Lang, T Neunteufl, M Kozinski, ...
Journal of Thrombosis and Haemostasis 10 (4), 529-542, 2012
1252012
Low‐molecular‐weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST‐elevation myocardial infarction: a meta‐analysis
EP Navarese, G De Luca, F Castriota, M Kozinski, PA Gurbel, CM Gibson, ...
Journal of Thrombosis and Haemostasis 9 (10), 1902-1915, 2011
1172011
Critical appraisal of inflammatory markers in cardiovascular risk stratification
M Krintus, M Kozinski, J Kubica, G Sypniewska
Critical reviews in clinical laboratory sciences 51 (5), 263-279, 2014
1152014
Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials
EP Navarese, J Kubica, F Castriota, CM Gibson, G De Luca, A Buffon, ...
EuroIntervention 7 (8), 985-994, 2011
1082011
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis
EP Navarese, AJ Lansky, DJ Kereiakes, J Kubica, PA Gurbel, DA Gorog, ...
European heart journal 42 (45), 4638-4651, 2021
1062021
Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
JM Siller-Matula, K Huber, G Christ, K Schrör, J Kubica, H Herkner, ...
Heart 97 (2), 98-105, 2011
1052011
Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors
J Kubica, A Kubica, B Jilma, P Adamski, EL Hobl, EP Navarese, ...
International Journal of Cardiology 215, 201-208, 2016
942016
Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome
EP Navarese, V Schulze, F Andreotti, M Kowalewski, M Kołodziejczak, ...
JACC: Cardiovascular Interventions 8 (1 Part B), 201-213, 2015
902015
The system can't perform the operation now. Try again later.
Articles 1–20